Hауково-Дослідний Інститут Мікробіології Та Імунології Ім. І.І. Мечникова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Українська Фармацевтична Академія, Украинская фармацевтическая академия, Hауково-Дослідний Інститут Мікробіології Та Імунології Ім. І.І. МечниковаfiledCriticalУкраїнська Фармацевтична Академія
Priority to UA96124562ApriorityCriticalpatent/UA22189A/en
Publication of UA22189ApublicationCriticalpatent/UA22189A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The task of this invention is to produce new substance, having antiviral activity against herpes simplex and vesicular stomatitis viruses. It is solved by preparation of II-karbethoxyphenylaconithymide, having the formula.
UA96124562A1996-12-051996-12-05ІІ- KARBETHOXYPHENYLACONITHYMIDE, SHOWING THE ACTIVITY AGAINST vesicular stomatitis VIRUS AND herpes simplex virus
UA22189A
(en)
"method of inhibiting virus replication, compound, method of inhibiting cytomegalovirus replication, antiviral compound, use of a compound, pharmaceutical composition, pharmaceutical composition inhibiting virus and cytomegalovirus replication and antiviral pharmaceutical composition"
Beta-d-glucosammonia salt of alpha-bromisovaleric acid possessing antiviral activities against vesicular stomatitis virus, herpes simplex virus, and coronavirus
1,1-bis -[2-(2,7-diacetoxy-fluorenylidene-9-hydrazono)-thiazolidone-4-yl -5]-o-nitrophenyl- methane exhibiting antiviral action against rna and dna viruses